Primary Care Congress for Cardiometabolic Health 2013
Agenda*
Day 1: Tuesday, April 23, 2013
|
7:00 |
AM |
Registration and Breakfast |
|
| ||
|
8:00 |
Welcome and Introduction | |
|
| ||
|
8:10 |
Pathophysiology of Type 2 Diabetes C. Ronald Kahn, MD | |
|
| ||
|
8:50 |
Inflammation in Coronary Artery Disease and the Etiology of the Cardiovascular Lesion Jorge Plutzky, MD, FACC | |
|
| ||
|
9:30 |
The Metabolic Syndrome: Is It a Valid Concept? Point Counterpoint Edward S. Horton, MD, Richard Kahn, MD | |
|
| ||
|
10:10 |
Break | |
|
| ||
|
10:25 |
The GI Tract in the Etiology of the Cardiometabolic Syndrome Suzanne Devkota, MD | |
|
| ||
|
11:10 |
Rheumatologic Disease and Coronary Artery Disease ? Is There a Link? Sukran Ergin, MD | |
|
| ||
|
12:00 |
PM |
Lunch |
|
| ||
|
12:40 |
Epidemiology of Diabetes and Cardiovascular Disease in Special Populations Enrique Caballero, MD, William C. Hsu, MD, Eyiuche Okeke, MD | |
|
| ||
|
1:20 |
New and Evolving Treatments for Type 2 Diabetes: Looking to the Horizon Martin J. Abrahamson, MD | |
|
| ||
|
2:00 |
New Insulins: The 1921 Discovery Keeps on Evolving Richard S. Beaser, MD | |
|
| ||
|
2:40 |
Break | |
|
| ||
|
2:55 |
New Perspectives on the Pathogenesis of Obesity Eleftheria Maratos-Flier, MD | |
|
| ||
|
3:45 |
Nutrition and Treatment for Cardiometabolic Risk: The Science and the Applications David Eisenberg, MD | |
|
| ||
|
4:35 |
Long-Term Weight Management in Obese Patients With Diabetes Osama Hamdy, MD, PhD, FACE | |
|
| ||
|
5:10 |
Panel Discussion and Questions on Case Vignette PM Faculty | |
|
| ||
|
5:40 |
Break | |
|
| ||
|
6:30 |
Introduction to Evening Session and Case Vignette: A Patient with Obesity and Type 2 Diabetes Osama Hamdy, MD, PhD, FACE | |
|
| ||
|
6:40 |
Effective Lifestyle Intervention That Finally Works Edward Phillips, MD | |
|
| ||
|
7:10 |
Pharmacotherapy of Obesity: To Use or Not to Use? Jody Dushay, MD, MMSe | |
|
| ||
|
7:40 |
Surgical Treatments for Obesity: Cutting to the Solution Robert Andrews, MD, FACS | |
|
| ||
|
8:10 |
Nonsurgical vs Surgical: Table Debates Osama Hamdy, MD, PhD, FACE | |
|
| ||
|
8:25 |
Express Debate of the Case All faculty plus RD, Exercise Physiologist | |
|
| ||
|
9:00 |
Adjournment | |
Day 2: Wednesday, April 24, 2013
|
7:00 |
AM |
Registration and Breakfast |
|
| ||
|
8:00 |
Introduction to Day 2 | |
|
| ||
|
8:10 |
Nonalcoholic Fatty Liver Disease Sanjiv Chopra, MBBS, MACP | |
|
| ||
|
8:50 |
Chronic Kidney Disease and Cardiovascular Risk: Interrelationships and Interventions Robert Stanton, MD | |
|
| ||
|
9:30 |
Dental and Cardiovascular Diseases: Are They Intertwined? William C. Hsu, MD | |
|
| ||
|
10:10 |
Break | |
|
| ||
|
10:25 |
Coronary Artery Disease in Women: Clinical perspectives JoAnn Manson, MD, DrPH | |
|
| ||
|
11:05 |
Modifying Atherosclerosis in Cardiometabolic Disease: Targeting Inflammation? Peter Libby, MD | |
|
| ||
|
11:35 |
PM |
Lunch |
|
| ||
|
12:25 |
Obesity, Fat, and Metabolism Aaron Cypess, MD, PhD, MMSc | |
|
| ||
|
1:10 |
Prevention Lessons from the DPP: Real-World Applications David Nathan, MD | |
|
| ||
|
2:00 |
Cardiometabolic Syndrome and Biological, Social, and Cultural Variability: Clinical Perspectives Enrique Caballero, MD | |
|
| ||
|
2:45 |
Break | |
|
| ||
|
3:10 |
Treating Hypertension in the Context of Cardiometabolic Risk Mark Williams, MD, FACE, FASN | |
|
| ||
|
3:40 |
Treating Dyslipidemia: An Evolving Paradigm Om Ganda, MD | |
|
| ||
|
4:10 |
New Approaches to, and Indications, for Antiplatelet Therapy Kenneth Bauer, MD | |
|
| ||
|
4:40 |
Panel Discussion PM Faculty | |
|
| ||
|
5:20 |
Break | |
|
| ||
|
6:30 |
Cardiometabolic Disease in Racial and Ethnic Minorities: Introduction Enrique Caballero, MD | |
|
| ||
|
6:40 |
Healthcare Disparities in Cardiometabolic Risk Gary Puckrein, PhD | |
|
| ||
|
7:10 |
Approaches to Reduce Cardiovascular Risk in Minorities Keith Ferdinand, MD, FACC, FAHA | |
|
| ||
|
7:40 |
Community-Based Interventions to Reduce CV Risk in Vulnerable Populations Enrique Caballero, MD | |
|
| ||
|
8:10 |
Panel Discussion: Effective Strategies to Eliminate Healthcare Disparities in Cardiometabolic Disease All Faculty | |
|
| ||
|
8:45 |
Q&A All Faculty | |
|
| ||
|
9:00 |
Adjournment | |
Day 3: Thursday, April 25, 2013
|
7:00 |
AM |
Breakfast |
|
| ||
|
8:10 |
Acute Coronary Syndromes: Prevention, Diagnosis, and Treatment Julian Aroesty, MD | |
|
| ||
|
8:50 |
Chronic Coronary Artery Disease Management Donald Cutlip, MD | |
|
| ||
|
9:30 |
Minimally Invasive Treatments for Vascular Disease: The Era of the Stent Duane Pinto, MD, MPH, FACC | |
|
| ||
|
10:10 |
Refreshment Break | |
|
| ||
|
10:25 |
Panel Discussion: Cardiometabolic Syndrome and CA AM Faculty | |
|
| ||
|
10:50 |
Interactive Case Sleep Apnea: Its Impact on Cardiovascular Disease Robert Thomas, MD | |
|
| ||
|
11:40 |
Androgen Deficiency and Coronary Artery Disease: Is There a Link? Martin Miner, MD | |
|
| ||
|
12:20 |
PM |
Closing Remarks and Adjournment Moderators |
Supporters

Page last updated: March 21, 2013

